This was directly confirmed by quantitative RT-PCR, whereby we demonstrated that CCI-006, unlike CCI-007, did not decrease the mRNA expression of leukemogenic MLL target genes HOXA9 and MEIS1 in MLL-r leukemia cells (Supplementary figure 7a). This evidence concerns the gene KMT2A and leukemia.